News

Filter by:
Filter by:
Lab
Topics

Scientists at the Whitehead Institute for Biomedical Research have discovered a glue-like protein in fruit flies that ensures proper partitioning of hereditary material and could shed new light on the origin of some of the most common human birth defects, including Down syndrome. Dr. Terry Orr-Weaver and her colleagues describe the new protein, called MEI-S332, and its role in sexual reproduction in the October 20 issue of Cell.

Scientists have created a new strain of mice lacking cyclin D1, a vital component of the growth machinery in all cells, and found that knocking out this important cog causes surprisingly little damage. These results have implications for treating human breast cancer and should lead to a better understanding of the molecular basis of cancer. The study, reported in the August 25 issue of Cell, was carried out in the laboratory of Dr. Robert Weinberg, a cancer research pioneer at the Whitehead Institute for Biomedical Research.

By teasing apart rapamycin’s activity at the cellular level, researchers at Whitehead Institute and the University of Pennsylvania have determined that inhibiting only the protein cluster known as the mechanistic target of rapamycin complex 1 (mTORC1) prolongs life in mice without adversely affecting glucose tolerance or insulin sensitivity.

A team of scientists from Whitehead Institute and other institutions has shown for the first time how two long intergenic noncoding RNAs (ncRNAs) in brewer’s yeast (Saccharomyces cerevisiae) contribute to a location-dependent switch for the yeast FLO11 gene to toggle between active and inactive states.

The entire Whitehead Institute community is profoundly saddened by news of Friday night's passing of John Pratt, the Institute’s former Associate Director and a central figure in establishing what would become one of the world’s preeminent biomedical research institutions.